Guardant Health (GH) PT Raised to $130 at JPMorgan
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $176.31 -0.48%
Rating Summary:
29 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
29 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
JPMorgan analyst Casey Woodring raised the price target on Guardant Health (NASDAQ: GH) to $130.00 (from $120.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Fortescue (FMG:AU) (FSUGY) PT Lowered to AUD18 at RBC Capital
- China Shenhua Energy (601088:CH) PT Raised to RMB53.60 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
